Inventor · disambiguated record
Nessan Bermingham
Also filed as: BERMINGHAM NESSAN · BERMINGHAM NESSAN A · BERMINGHAM NESSAN ANTHONY
13 granted patents·11 pending applications·67 citations·filing 2000–2025
90Inventor score
Files withKORRO BIO INC10TAKEDA PHARMACEUTICALS USA INC5TRIPLET THERAPEUTICS INC5BAYLOR COLLEGE MEDICINE4
Top patents by PatentIndex Score
24 records- 0195US11479575B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2020·Granted Oct 25, 2022·5 cites·17 claims
- 0294US11453878B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2020·Granted Sep 27, 2022·5 cites·18 claims
- 0393US12031131B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2023·Granted Jul 9, 2024·1 cites·27 claims
- 0492US12448620B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2022·Granted Oct 21, 2025·1 cites·20 claims
- 0592US12173285B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2023·Granted Dec 24, 2024·1 cites·28 claims
- 0692US12152050B2RNA-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2022·Granted Nov 26, 2024·1 cites·17 claims
- 0786US11408000B2Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activityTRIPLET THERAPEUTICS INC·Filed 2021·Granted Aug 9, 2022·2 cites·10 claims
- 0885US2025382610A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2025·Application pending·0 cites
- 0984US7053200B1Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferationBAYLOR COLLEGE MEDICINE·Filed 2000·Granted May 30, 2006·21 cites·3 claims
- 1083US6838444B1Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferationBAYLOR COLLEGE MEDICINE·Filed 2000·Granted Jan 4, 2005·19 cites·15 claims
- 1183US2025215038A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2024·Application pending·0 cites
- 1280US2025066773A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2024·Application pending·0 cites
- 1377US12297432B2Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activityTAKEDA PHARMACEUTICALS USA INC·Filed 2022·Granted May 13, 2025·0 cites·9 claims
- 1474US7470673B2Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferationBAYLOR COLLEGE MEDICINE·Filed 2004·Granted Dec 30, 2008·7 cites·8 claims
- 1572US2025327073A1Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with msh3 activityTAKEDA PHARMACEUTICALS USA INC·Filed 2025·Application pending·0 cites
- 1669US7442688B2Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferationBAYLOR COLLEGE MEDICINE·Filed 2004·Granted Oct 28, 2008·4 cites·8 claims
- 1767US2025207129A1Methods for the treatment of neurodegenerative disordersTAKEDA PHARMACEUTICALS USA INC·Filed 2023·Application pending·0 cites
- 1863US2024263179A1Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activityTAKEDA PHARMACEUTICALS USA INC·Filed 2022·Application pending·0 cites
- 1962US2020385713A1Rna-editing oligonucleotides and uses thereofKORRO BIO INC·Filed 2020·Application pending·0 cites
- 2056US12485136B2Methods for the treatment of trinucleotide repeat expansion disorders associated with MLH3 activityTAKEDA PHARMACEUTICALS USA INC·Filed 2019·Granted Dec 2, 2025·0 cites·9 claims
- 2147US2023313185A1Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activityTRIPLET THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2245US2023041178A1Methods for the treatment of trinucleotide repeat exapnsion disorders associated with ogg1 activityTRIPLET THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2341US2022072028A1Methods for the treatment of trinucleotide repeat expansion disorders associated with msh3 activityTRIPLET THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2441US2022033814A1Methods for the treatment of trinucleotide repeat expansion disorders associated with mlh1 activityTRIPLET THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nessan Bermingham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →